Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
This article explains the data types used in index level calculations, from price data to breadth indicators, and how each input influences the final level.
28,296 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
May layoff activity surged to 97,006, with AI cited as the primary driver for a third straight month. Tech firms led ...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
Bank of America signals three quarter-point rate increases in 2026, rattling lenders and borrowers alike. Here’s what...
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
NVIDIA's CEO hints that the next wave of wealth could come from skilled trades like plumbing and electrical work, pro...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
As U.S. AI export controls tighten, investors face a push-pull: tighter access could spur China’s open-source AI ecos...
AMD jumps 8% mid-session as quarterly results highlight data-center momentum, prompting questions about whether it is...
A Chinese AI model is reported to rival US leaders in performance, sparking a reassessment of investments in data cen...
A real estate reform push proposes agent ownership of the national MLS and portal, aiming to reshape loan access, pri...
Memory names rebound sharply as AI-driven data-center demand returns, led by Western Digital and Seagate’s roughly 7%...